Massachusetts General Hospital

Biography

Dr. Lubitz received her medical degree at the University of Michigan Medical School. Following her internship at the University of Michigan, she then moved to New York Presbyterian Hospital for her general surgical training. In 2009, Dr. Lubitz completely her clinical endocrine surgery fellowship at the Massachusetts General Hospital and is now an Instructor of Surgery at the Harvard Medical School. Dr. Lubitz' clinical area of expertise is endocrine surgery and is a member of the MGH Endocrine Surgery Unit, the highest volume center in the country focused on surgery of the thyroid, parathyroid, and adrenal glands. Her particular areas of clinical expertise are in the treatment of thyroid cancer, minimally-invasive parathyroidectomy, and the surgical treatment of adrenal tumors. In addition to his clinical practice, Dr. Lubitz' has clinical and translational research interests including prediction modeling for thyroid cancer recurrence and comparative effectiveness of diagnostic and treatment algorithms for endocrine-related disorders.

Research

Dr. Lubitz' research interests have centered on the diagnosis and treatment of thyroid cancer with both basic science and clinical research projects. During residency, she studied the genetic basis of thyroid cancer as a postdoctoral research fellow in surgical oncology. During her endocrine surgery fellowship, she continued to investigate endocrine oncology through a number of clinical research projects including a project identifying clinical and cytological variables associated with malignancy in thyroid nodules and a second project assessing the accuracy of a novel parathyroid imaging dual-phased contrast computed tomography platform. She is currently obtaining her Master of Public Health through the Harvard School of Public Health. Her current research interests are in comparative effectiveness and appropriateness of care research to assess the current diagnostic, treatment, and surveillance paradigms in endocrine-related disorders. Dr. Lubitz was accepted into the 2011 Program in Cancer Outcomes Research Training (PCORT) program. This two-year National Cancer Institute-funded, curriculum based, interdisciplinary research fellowship program involves faculty from across the entire Dana-Farber/Harvard Cancer Center and affiliated institutions. The goal of the program is to train pre- and post-doctoral fellows to become leaders in cancer outcomes research.

Publications

View my most recent publications at PubMed